Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 17/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20201129 | 0.88 | APLNR (0.42) | APLNR | |
| SCHEMBL22810446 | 0.87 | APLNR (0.41) | APLNR | |
| SCHEMBL20201117 | 0.86 | APLNR (0.42) | APLNRPOLBMEN1KMT2ASIRT5 | |
| SCHEMBL20200894 | 0.85 | ALDH1A1 (0.49) | APLNRPOLBMEN1KMT2ASIRT5 | |
| SCHEMBL21339359 | 0.85 | APLNR (0.46) | APLNR | |
| SCHEMBL20201084 | 0.81 | APLNR (0.47) | APLNR | |
| SCHEMBL20201124 | 0.81 | APLNR (0.40) | APLNRALDH1A1NPC1 | |
| SCHEMBL20201030 | 0.81 | APLNR (0.48) | APLNR | |
| SCHEMBL21339409 | 0.80 | APLNR (0.47) | APLNR | |
| SCHEMBL21339423 | 0.79 | APLNR (0.45) | APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3541792-B1 | TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC (US) | 2020-12-23 | — | — | EP | disclosed |
| WO-2018097944-A1 | TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC. (US) | 2018-05-31 | — | — | WO | disclosed |